Determinants of antibody responses to two doses of ChAdOx1 nCoV-19 or BNT162b2 and a subsequent booster dose of BNT162b2 or mRNA-1273: population-based cohort study (COVIDENCE UK)
David A Jolliffe, Sian E Faustini, Hayley Holt, Natalia Perdek, Sheena Maltby, View ORCID ProfileMohammad Talaei, Matthew Greenig, Giulia Vivaldi, Florence Tydeman, Jane Symons, Gwyneth A Davies, Ronan A Lyons, Christopher J Griffiths, Frank Kee, Aziz Sheikh, Seif O Shaheen, View ORCID ProfileAlex G Richter, View ORCID ProfileAdrian R Martineau
doi: https://doi.org/10.1101/2022.02.14.22270930
David A Jolliffe
1Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
2Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Sian E Faustini
3Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
Hayley Holt
1Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
2Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
4Asthma UK Centre for Applied Research, Queen Mary University of London, London, UK
Natalia Perdek
1Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Sheena Maltby
1Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Mohammad Talaei
2Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Matthew Greenig
1Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Giulia Vivaldi
1Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
2Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Florence Tydeman
1Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
2Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Jane Symons
5Jane Symons Media, London, UK
Gwyneth A Davies
6Population Data Science, Swansea University Medical School, Singleton Park, Swansea, UK
Ronan A Lyons
6Population Data Science, Swansea University Medical School, Singleton Park, Swansea, UK
Christopher J Griffiths
2Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
4Asthma UK Centre for Applied Research, Queen Mary University of London, London, UK
Frank Kee
7Centre for Public Health Research (NI), Queen’s University Belfast, Belfast, UK
Aziz Sheikh
8Usher Institute, University of Edinburgh, Edinburgh, UK
Seif O Shaheen
2Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Alex G Richter
3Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
Adrian R Martineau
1Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
2Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
4Asthma UK Centre for Applied Research, Queen Mary University of London, London, UK
Data Availability
De-identified participant data will be made available upon reasonable request to the corresponding author, subject to terms of research ethics committee approval and Sponsor requirements.
Posted February 15, 2022.
Determinants of antibody responses to two doses of ChAdOx1 nCoV-19 or BNT162b2 and a subsequent booster dose of BNT162b2 or mRNA-1273: population-based cohort study (COVIDENCE UK)
David A Jolliffe, Sian E Faustini, Hayley Holt, Natalia Perdek, Sheena Maltby, Mohammad Talaei, Matthew Greenig, Giulia Vivaldi, Florence Tydeman, Jane Symons, Gwyneth A Davies, Ronan A Lyons, Christopher J Griffiths, Frank Kee, Aziz Sheikh, Seif O Shaheen, Alex G Richter, Adrian R Martineau
medRxiv 2022.02.14.22270930; doi: https://doi.org/10.1101/2022.02.14.22270930
Determinants of antibody responses to two doses of ChAdOx1 nCoV-19 or BNT162b2 and a subsequent booster dose of BNT162b2 or mRNA-1273: population-based cohort study (COVIDENCE UK)
David A Jolliffe, Sian E Faustini, Hayley Holt, Natalia Perdek, Sheena Maltby, Mohammad Talaei, Matthew Greenig, Giulia Vivaldi, Florence Tydeman, Jane Symons, Gwyneth A Davies, Ronan A Lyons, Christopher J Griffiths, Frank Kee, Aziz Sheikh, Seif O Shaheen, Alex G Richter, Adrian R Martineau
medRxiv 2022.02.14.22270930; doi: https://doi.org/10.1101/2022.02.14.22270930
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (716)
- Anesthesia (210)
- Cardiovascular Medicine (2995)
- Dermatology (254)
- Emergency Medicine (447)
- Epidemiology (12887)
- Forensic Medicine (12)
- Gastroenterology (840)
- Genetic and Genomic Medicine (4679)
- Geriatric Medicine (429)
- Health Economics (738)
- Health Informatics (2976)
- Health Policy (1080)
- Hematology (396)
- HIV/AIDS (942)
- Medical Education (436)
- Medical Ethics (116)
- Nephrology (479)
- Neurology (4465)
- Nursing (239)
- Nutrition (655)
- Oncology (2321)
- Ophthalmology (659)
- Orthopedics (261)
- Otolaryngology (330)
- Pain Medicine (289)
- Palliative Medicine (85)
- Pathology (506)
- Pediatrics (1210)
- Primary Care Research (507)
- Public and Global Health (7058)
- Radiology and Imaging (1568)
- Respiratory Medicine (930)
- Rheumatology (447)
- Sports Medicine (389)
- Surgery (495)
- Toxicology (61)
- Transplantation (214)
- Urology (186)